Follow
Bruno FANTIN
Bruno FANTIN
Pr médecine interne, Univ Paris 7
Verified email at aphp.fr
Title
Cited by
Cited by
Year
Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19
E Garrigues, P Janvier, Y Kherabi, A Le Bot, A Hamon, H Gouze, L Doucet, ...
Journal of Infection 81 (6), e4-e6, 2020
11862020
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ...
The Lancet Infectious Diseases 17 (5), 510-519, 2017
4702017
Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models
JE Leggett, B Fantin, S Ebert, K Totsuka, B Vogelman, W Calame, ...
Journal of infectious diseases 159 (2), 281-292, 1989
4081989
Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection …
JE Leggett, S Ebert, B Fantin, WA Craig
Scand J Infect Dis 74 (Suppl 1), 179-184, 1991
1911991
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams
E Weiss, JR Zahar, P Lesprit, E Ruppe, M Leone, J Chastre, JC Lucet, ...
Clinical Microbiology and Infection 21 (7), 649. e1-649. e10, 2015
1702015
The French Gaucher’s disease registry: clinical characteristics, complications and treatment of 562 patients
J Stirnemann, M Vigan, D Hamroun, D Heraoui, L Rossi-Semerano, ...
Orphanet journal of rare diseases 7, 1-13, 2012
1562012
Ciprofloxacin dosage and emergence of resistance in human commensal bacteria
B Fantin, X Duval, L Massias, L Alavoine, F Chau, S Retout, A Andremont, ...
Journal of Infectious Diseases 200 (3), 390-398, 2009
1542009
In vivo antibiotic synergism: contribution of animal models
B Fantin, C Carbon
Antimicrobial Agents and Chemotherapy 36 (5), 907-912, 1992
1521992
Prediction of the intestinal resistome by a three-dimensional structure-based method
E Ruppé, A Ghozlane, J Tap, N Pons, AS Alvarez, N Maziers, T Cuesta, ...
Nature microbiology 4 (1), 112-123, 2019
1512019
A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial
BD Huttner, V De Lastours, M Wassenberg, N Maharshak, A Mauris, ...
Clinical microbiology and infection 25 (7), 830-838, 2019
1502019
Medical complications following splenectomy
R Buzelé, L Barbier, A Sauvanet, B Fantin
Journal of visceral surgery 153 (4), 277-286, 2016
1432016
Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia
A Lefort, X Panhard, O Clermont, PL Woerther, C Branger, F Mentré, ...
Journal of clinical microbiology 49 (3), 777-783, 2011
1402011
Evaluation of the management of postoperative aseptic meningitis
V Zarrouk, I Vassor, F Bert, D Bouccara, M Kalamarides, N Bendersky, ...
Clinical infectious diseases 44 (12), 1555-1559, 2007
1362007
Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli
B Fantin, S Ebert, J Leggett, B Vogelman, WA Craig
Journal of antimicrobial chemotherapy 27 (6), 829-836, 1991
1221991
Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin
OA Cornely, MA Miller, B Fantin, K Mullane, Y Kean, S Gorbach
J Clin Oncol 31 (19), 2493-2499, 2013
1182013
Comparative study of postoperative and spontaneous pyogenic spondylodiscitis
V Dufour, A Feydy, L Rillardon, A Redondo, L Le Page, F Bert, ...
Seminars in arthritis and rheumatism 34 (5), 766-771, 2005
1172005
Imaging does not predict the clinical outcome of bacterial vertebral osteomyelitis
V Zarrouk, A Feydy, F Salles, V Dufour, P Guigui, A Redondo, B Fantin
Rheumatology 46 (2), 292-295, 2007
1122007
Resistance to Quinupristin-Dalfopristin Due to Mutation of L22 Ribosomal Protein in Staphylococcus aureus
B Malbruny, A Canu, B Bozdogan, B Fantin, V Zarrouk, S Dutka-Malen, ...
Antimicrobial agents and chemotherapy 46 (7), 2200-2207, 2002
1112002
Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model
B Fantin, J Leggett, S Ebert, WA Craig
Antimicrobial agents and chemotherapy 35 (7), 1413-1422, 1991
1101991
Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli …
N Allou, E Cambau, L Massias, F Chau, B Fantin
Antimicrobial agents and chemotherapy 53 (10), 4292-4297, 2009
952009
The system can't perform the operation now. Try again later.
Articles 1–20